Autor del archivo

orixwp

This information box about the author only appears if the author has biographical information. Otherwise there is not author box shown. Follow YOOtheme on Twitter or read the blog.

Recursos

[Palliative treatment of malignant gastric outlet obstruction].

Related Articles [Palliative treatment of malignant gastric outlet obstruction]. Ugeskr Laeger. 2016 May 30;178(22): Authors: Würtz HJ, Ainsworth AP Abstract In gastric outlet obstruction (GOO) the passage from the stomach to the intestine is obstructed. The condition is referred to as malignant GOO if cancer is the reason. Self-expanding metal stents (SEMS) and gastrojejunostomy (GEA) are the therapeutic options for palliation, with SEMS often being recommended as first choice. However, no major difference in terms of clinical success has been shown between SEMS and GEA in comparative studies. Thus, the choice between SEMS and GEA should be made on an…
Origen: [Palliative treatment of malignant gastric outlet obstruction]. – PubMed

Leer más

Recursos

[Treatment of constipation in palliative care patients is a challenge].

Related Articles [Treatment of constipation in palliative care patients is a challenge]. Ugeskr Laeger. 2016 Aug 15;178(33): Authors: Jarlbæk L, Johnsen B, Hansen OB, Hedal B Abstract The evidence for treatment of constipation in palliative care patients is poor. The condition of these patients is often complex, and results from studies performed in other patient groups cannot be extrapolated unconditionally. However, macrogol (polyethylene glycol), lactulose and sodium picosulphate seem to be well tolerated, and methylnaltrexone could be used in opioid-induced constipation, if the patients are not at risk from gastrointestinal perforation. The patients should be offered quiet and private surroundings,…
Origen: [Treatment of constipation in palliative care patients is a challenge]. – PubMed

Leer más

Recursos

Chronic Pruritus in the Geriatric Population.

Related Articles Chronic Pruritus in the Geriatric Population. Dermatol Clin. 2018 Jul;36(3):199-211 Authors: Cao T, Tey HL, Yosipovitch G Abstract Chronic pruritus (>6 week’s duration) in the geriatric population (≥65 years old), is an increasing health care problem. The pathophysiologic predisposing factors are abnormalities of the epidermal barrier, immune system, and nervous system. Causes can be dichotomized into histaminergic and nonhistaminergic pruritus. Topical treatments are generally safe. Systemic treatments are chosen depending on the condition, comorbid diseases, and drug interactions. Treatment options are limited. Progress has been made in identifying itch-selective mediators over the last decade. Numerous new medications are currently…
Origen: Chronic Pruritus in the Geriatric Population. – PubMed

Leer más

Recursos

Diagnosis and Multimodal Treatment of Metastatic Maxillofacial Juvenile Embryonal Rhabdomyosarcoma in a Young Golden Retriever.

Related Articles Diagnosis and Multimodal Treatment of Metastatic Maxillofacial Juvenile Embryonal Rhabdomyosarcoma in a Young Golden Retriever. J Am Anim Hosp Assoc. 2018 Sep/Oct;54(5):e54505 Authors: Gillem JM, Sullivan L, Sorenmo KU Abstract A 2 yr old male castrated golden retriever was evaluated for a rapidly progressing maxillofacial spindle cell tumor. On examination, an ill-defined left maxillary mass, a 2 cm swelling under the left eye, and an enlarged left mandibular lymph node were noted. The dog was bright and alert but appeared painful upon jaw extension. Cytology from the lymph node revealed metastatic disease. Thoracic radiographs and computed tomography scan…
Origen: Diagnosis and Multimodal Treatment of Metastatic Maxillofacial Juvenile Embryonal Rhabdomyosarcoma in a Young Golden Retriever. – PubMed

Leer más

Recursos

Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma.

Related Articles Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma. Sci Rep. 2017 03 14;7:44282 Authors: Cho SF, Liu YC, Hsiao HH, Huang CT, Tsai YF, Wang HC, Lin SF, Liu TC Abstract This study aimed to investigate the treatment strategy, prognostic factors, and risk factors of early death in elderly patients (age ≥ 65 years) with diffuse large B-cell lymphoma (DLBCL) in the rituximab era. Data from elderly patients diagnosed with DLBCL between 2008 and 2014 were collected for analysis. Patients who were younger and had a better…
Origen: Investigation on treatment strategy, prognostic factors, and risk factors for early death in elderly Taiwanese patients with diffuse large B-cell lymphoma. – PubMed

Leer más